title: Hydralazine vs labetalol for the treatment of severe hypertensive disorders of pregnancy. A randomized, controlled trial.
abstract: Hydralazine and labetalol for intravenous use are equally effective in the management of hypertensive crisis in pregnant patients (24weeks or more) with severe hypertensive disorders of pregnancy, showing a similar frequency of adverse effects in both groups.
authors.affiliation: Saint Thomas Maternity Hospital, Coordination of Research, Panama.
authors.forename: Samuel
authors.initials: S
authors.lastname: Delgado De Pasquale
authors.affiliation: Saint Thomas Maternity Hospital, Coordination of Research, Panama.
authors.forename: Rodrigo
authors.initials: R
authors.lastname: Velarde
authors.affiliation: Saint Thomas Maternity Hospital, Coordination of Research, Panama. Electronic address: oreyespanama@yahoo.es.
authors.forename: Osvaldo
authors.initials: O
authors.lastname: Reyes
authors.affiliation: Saint Thomas Maternity Hospital, Coordination of Research, Panama.
authors.forename: Kerima
authors.initials: K
authors.lastname: De La Ossa
keywords: Hydralazine; Hypertensive crisis; Labetalol; Persistent hypertension; Severe hypertensive disorders of pregnancy